Well Here we go again

Apparently I am not Her2-Negative...After a call from the Oncologist today I find out that I am after all Her2-Positive and so I will not be taking Adventist I will be taking :


What is Herceptin?
Herceptin (trastuzumab) is a treatment for women with breast cancer whose tumors have too much HER2 protein. This type of cancer is known as "HER2-positive," "HER2+," or "HER2-overexpressing." HER2+ tumors tend to grow and spread more quickly than tumors that are not HER2+. This is why it is so important to find out your cancer's HER2 status. ^1,2
Clinical experience with Herceptin for the adjuvant treatment of HER2+ breast cancer began in 2000. ² In 2006, Herceptin was approved for the adjuvant treatment of HER2+ breast cancer. ¹

Who is Herceptin for?

Herceptin is approved for the adjuvant treatment of HER2-overexpressing, node-positive or node-negative (ER/PR-negative or with one high-risk feature)^† breast cancer. Herceptin can be used several different ways:

• As part of a treatment regimen including doxorubicin, cyclophosphamide, and either paclitaxel or docetaxel
• With docetaxel and carboplatin
• As a single agent following multi-modality anthracycline-based therapy

† High-risk is defined as ER/PR positive with one of the following features: tumor size >2 cm, age <35 years, or tumor grade 2 or 3.

High-risk features are defined as ER/PR+ with one of the following characteristics:

• Age less than 35 years
• Tumor size larger than 2 cm wide
• Tumor grade 2/3

So now we are on the same page as everyone now apparently with this cancer is the only choice.

My next appt is Tuesday to find out more and see when the treatment starts. There does seem to be a lot of side affects with this ...Very worrying to say the least.